SG11201806177QA - Transplant material for treatment of heart disease - Google Patents
Transplant material for treatment of heart diseaseInfo
- Publication number
- SG11201806177QA SG11201806177QA SG11201806177QA SG11201806177QA SG11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA SG 11201806177Q A SG11201806177Q A SG 11201806177QA
- Authority
- SG
- Singapore
- Prior art keywords
- heart disease
- treatment
- transplant material
- heart
- transplant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
TRANSPLANT MATERIAL FOR TREATMENT OF HEART DISEASE [] It has been found that a cell cluster obtained by causing just isolated cells to adhere to each other 5 secretes adiponectin after transplantation to the heart, and thereby has an excellent therapeutic effect on heart disease. Figures 4A, 4B and 4C 10
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016008096 | 2016-01-19 | ||
PCT/JP2017/001538 WO2017126549A1 (en) | 2016-01-19 | 2017-01-18 | Transplant material for therapy for heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201806177QA true SG11201806177QA (en) | 2018-08-30 |
Family
ID=59362376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201806177QA SG11201806177QA (en) | 2016-01-19 | 2017-01-18 | Transplant material for treatment of heart disease |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210187031A1 (en) |
EP (1) | EP3406255B1 (en) |
JP (1) | JP6854519B2 (en) |
CN (1) | CN108472319B (en) |
SG (1) | SG11201806177QA (en) |
WO (1) | WO2017126549A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190255116A1 (en) * | 2016-10-18 | 2019-08-22 | Osaka University | Kit for preparing disease-treating agent, disease-treating agent and method for preparing disease-treating agent |
JPWO2019132025A1 (en) | 2017-12-28 | 2020-12-10 | 株式会社カネカ | Cell population containing adherent stem cells, method for producing the same, and pharmaceutical composition |
EP3750987A4 (en) | 2017-12-28 | 2021-11-10 | Kaneka Corporation | Cell population including adhesive stem cells, production method therefor, and pharmaceutical composition |
WO2019187918A1 (en) * | 2018-03-29 | 2019-10-03 | 国立大学法人 琉球大学 | Method for preventing incorporation of undifferentiated ips cells possibly having tumorigenic potential using differentiation-controlling compound |
WO2020184350A1 (en) | 2019-03-08 | 2020-09-17 | 株式会社カネカ | Mass culture of pluripotent stem cells |
EP4026551A1 (en) * | 2019-09-05 | 2022-07-13 | Tohoku University | Therapeutic agent for myocarditis |
JP7495075B2 (en) | 2019-12-25 | 2024-06-04 | ロート製薬株式会社 | Hypertensive heart disease treatment |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005047491A2 (en) * | 2003-11-10 | 2005-05-26 | Amgen Inc. | Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy |
WO2006127007A2 (en) * | 2005-05-25 | 2006-11-30 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
CN101517069A (en) * | 2006-07-13 | 2009-08-26 | 塞拉帝思股份公司 | A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells |
GB2452466B (en) * | 2006-07-13 | 2011-08-31 | Cellartis Ab | A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells |
EP2166084A4 (en) * | 2007-06-14 | 2010-06-23 | Found Biomedical Res & Innov | Multipotent progenitor cell derived from adipose tissue |
EP2825638A4 (en) * | 2012-03-12 | 2015-11-25 | Univ Singapore | Generation of brown adipose tissue (bat) from mesenchymal cells |
US9644181B2 (en) * | 2012-04-25 | 2017-05-09 | Riken | Cell preparation containing myocardium-committed cell |
-
2017
- 2017-01-18 CN CN201780006848.7A patent/CN108472319B/en active Active
- 2017-01-18 US US16/071,123 patent/US20210187031A1/en active Pending
- 2017-01-18 WO PCT/JP2017/001538 patent/WO2017126549A1/en active Application Filing
- 2017-01-18 SG SG11201806177QA patent/SG11201806177QA/en unknown
- 2017-01-18 JP JP2017562848A patent/JP6854519B2/en active Active
- 2017-01-18 EP EP17741426.5A patent/EP3406255B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2017126549A1 (en) | 2017-07-27 |
CN108472319A (en) | 2018-08-31 |
JPWO2017126549A1 (en) | 2018-11-08 |
CN108472319B (en) | 2021-12-28 |
EP3406255A1 (en) | 2018-11-28 |
EP3406255A4 (en) | 2019-08-14 |
EP3406255B1 (en) | 2023-06-07 |
US20210187031A1 (en) | 2021-06-24 |
EP3406255C0 (en) | 2023-06-07 |
JP6854519B2 (en) | 2021-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201806177QA (en) | Transplant material for treatment of heart disease | |
MX2019014009A (en) | Improved methods for manufacturing adoptive cell therapies. | |
WO2016012544A3 (en) | Enhanced reprogramming to ips cells | |
WO2016090178A3 (en) | Processes for producing exosomes in reduced oxygen culture conditions | |
NZ731789A (en) | Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof | |
TW201612312A (en) | Meristematic plant cells and method of isolating them | |
PH12017501218A1 (en) | Rpe cell populations and methods of generating same | |
EP4275746A3 (en) | Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use | |
MX2021000459A (en) | Method for producing î³î´ t cells. | |
MX2020005640A (en) | Humanized anti-liv1 antibodies for the treatment of breast cancer. | |
WO2018146679A3 (en) | Photoreceptor cells for the treatment of retinal diseases | |
EA201890442A1 (en) | OBTAINING PHOTORECEPTORS FOR THE TREATMENT OF RETITAL DISEASES | |
MX2020011254A (en) | Anti-bcma car-t-cells for plasma cell depletion. | |
AU2018337668A1 (en) | Improved supraparticles | |
EP3719890A4 (en) | Negative electrode active substance and production method therefor | |
EP3641807A4 (en) | Adoptive t cell therapy 2 | |
EP3608398A4 (en) | Cell cultivation method, cell support composite production method, cultivated cells, and cell support composite | |
EP3890073A4 (en) | Negative electrode material, battery and method for producing battery | |
MX2018002816A (en) | Methods of treating multiple myeloma and plasma cell leukemia by t cell therapy. | |
EP3587559A4 (en) | Production method for artificial pluripotent stem cells | |
EP3812451A4 (en) | Cell stimulation device, cell stimulation method, production method for culture product, production method for isolated cells, and cell proliferation method | |
PH12019501133A1 (en) | Manufacturing optimization of gl-2045, a multimerizing stradomer | |
SG10201811177SA (en) | Cell culture methods and media comprising n-acetylcysteine | |
MX2016014628A (en) | Method for expanding adult stem cells from whole blood. | |
EP3684798A4 (en) | Cell culture additives and their use for increased bioprotein production from cells |